
Apeptico completes €3.4m financing round
18.05.2012 Austrian peptide drug developer Apeptico F&E GmbH has secured €3.4m financing. more
EuroBiotechNews


18.05.2012 Austrian peptide drug developer Apeptico F&E GmbH has secured €3.4m financing. more
16.05.2012 Britain's largest drugmaker GlaxoSmithKline will pay about €75m in cash to acquire Cellzome AG completely.more
15.05.2012 F-Star's management has been lifted and replaced by a troika of new leaders. more

By drawing lines and figures in the sand with their hands sand animators create a series of images… more

Ray Cokes was once a famous MTV presenter. In this crazy commercial he presents Boehringer's latest… more

They are essential for every PCR: Small PCR Tubes. But the tiny, colourful tubes have abilities… more

Forget about serial delutions, spatula and Bunsen burner. With Eddy Jet plates are processed in… more

What comes to your mind when you think about the Netherlands? Flowers? Cheese? Life Sciences? Yes!… more

This is the winner of the Lab Grammy Awards 2012 starring Beaker from the muppets as a distressed… more

Arnold Young was an A+ student, and is now ready to take over the world of science! He soon… more

How would Lady Gaga perform one of her greatest hits in a lab? With over three million views on… more
© 2007-2012 BIOCOM
http://www.eurobiotechnews.eu/

A non-enzymatic approach that prevents biochemical degradation during processing and overcomes the problems associated with extracting cells from 3D culture. more